|
⚲
|
| Keyboard |
| Monocacy Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002137361 |
| Sale | 2026-09-03 (0.0 M Offered, 0.0 M Sold) |
| Fund | |
| Phone | 3019790911 |
| Address | 4716 Monrovia Blvd Monrovia, MD 21770 |
| Source | [EDGAR] |
| Amount Raised ($) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Shashank Patel | Executive Officer | |
| Suman Vodnala | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Fort LP
✚
|
MD | |
|
Baltimore Capital Management Inc
✚
|
MD | |
|
Price T Rowe Associates Inc /MD/
✚
|
MD | |
|
Resolve Growth Partners Management Co LLC
✚
|
MD | |
|
Singh Capital Partners LLC
✚
|
MD | |
|
Cambium Capital Management LP
✚
|
MD | |
|
WMS Partners LLC
✚
|
MD | |
|
Legg Mason Wood Walker Incorporated
✚
|
MD | |
|
AGNC Management LLC
✚
|
MD | |
|
Planning Solutions Group LLC
✚
|
MD |